3'UTR sequence for transgene expression
US12203085B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2021 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Apr 12, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA01H6/604
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This disclosure concerns compositions and methods for promoting transcription of a nucleotide sequence in a plant or plant cell, employing a promoter from a Glycine max egg cell gene. Some embodiments relate to a promoter or a 5′ UTR from a Glycine max egg cell gene that functions in plants to promote transcription of operably linked nucleotide sequences. Other embodiments relate to a 3′ UTR or a terminator from a Glycine max egg cell gene that functions in plants to promote transcription of operably linked nucleotide sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.